Metastasis dynamics for non-small-cell lung cancer: Effect of patient and tumor-related factors

Clinical Lung Cancer

Volumn 14, Issue 4, 2013, Pages 425-432

  Kelsey, Chris R ^a   Fornili, Marco ^b   Ambrogi, Federico ^b   Higgins, Kristin ^c   Boyd, Jessamy A ^d   Biganzoli, Elia ^b   Demicheli, Romano ^e  

^a DUKE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEXAS ONCOLOGY   (United States)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Lung cancer biology; Metastasis; Risk analysis modeling; Statistics

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; SEX DIFFERENCE; TUMOR INVASION;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84878785466     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.01.002     Document Type: Article

References (23)

1. A. Jemal, R. Siegel, J. Xu Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. M. Malvezzi, A. Arfé, P. Bertuccio European cancer mortality predictions for the year 2011 Ann Oncol 22 2011 947 956
3. R. Arriagada, B. Bergman, A. Dunant Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
4. J.Y. Douillard, R. Rosell, M. De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 2006 719 727
5. T. Winton, R. Livingston, D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597
6. M.K. Bae, C.S. Byun, C.Y. Lee The role of surgical treatment in second primary lung cancer Ann Thorac Surg 92 2011 256 262
7. C.R. Kelsey, L.B. Marks, D. Hollis Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients Cancer 115 2009 5218 5227
8. J.M. Pepek, J.P. Chino, L.B. Marks How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: a comparison of the TNM 6 and 7 systems J Thorac Oncol 6 2011 757 761
9. J.A. Boyd, J.L. Hubbs, D.W. Kim Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure J Thorac Oncol 5 2010 211 214
10. R.J. Simes, M. Zelen Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer J Clin Oncol 3 1985 1418 1431
11. R. Demicheli, M. Fornili, F. Ambrogi Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases J Thorac Oncol 7 2012 723 730
12. R. Demicheli, M.W. Retsky, W.J. Hrushesky Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures Nat Clin Pract Oncol 4 2007 699 710
13. H. Ramlau-Hansen Smoothing counting process intensities by means of kernel functions Ann Statist 11 1983 453 466
14. P. Boracchi, E. Biganzoli, E. Marubini Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients Comput Statist Data Anal 42 2003 243 262
15. H. Sakurai, H. Asamura, T. Goya Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese lung cancer registry study J Thorac Oncol 5 2010 1594 1601
16. S.L. McGovern, Z. Liao, M.K. Bucci Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? Cancer 115 2009 3233 3242
17. P. Wheatley-Price, F. Blackhall, S.M. Lee The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials Ann Oncol 21 2010 2023 2028
18. H. Nakamura, K. Ando, T. Shinmyo Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis Ann Thorac Cardiovasc Surg 17 2011 469 480
19. R. Demicheli, E. Biganzoli, P. Boracchi Recurrence dynamics does not depend on the recurrence site Breast Cancer Res 10 2008 R83
20. K.A. Higgins, J.P. Chino, N. Ready Lymphovascular invasion in non-small-cell lung cancer Implications for staging and adjuvant therapy J Thorac Surg 7 2012 1141 1147
21. R. Demicheli, M.W. Retsky, W.J. Hrushesky The effects of surgery on tumor growth: a century of investigations Ann Oncol 19 2008 1821 1828
22. G.N. Naumov, J. Folkman, O. Straume Tumor-vascular interactions and tumor dormancy APMIS 116 2008 569 585
23. G.L. Walsh, M. O'Connor, K.M. Willis Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 60 1995 1563 1570 discussion 1570-2